Omada Health (NASDAQ:OMDA) Given New $22.00 Price Target at Barclays

Omada Health (NASDAQ:OMDA) had its price objective lowered by Barclays from $24.00 to $22.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Other equities analysts have also recently issued reports about the company. BMO Capital Markets reissued an “outperform” rating and set a $24.00 target price on shares of Omada Health in a research note on Friday, August 7th. Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 price target on shares of Omada Health in a research note on Friday, September 11th. Weiss Ratings cut shares of Omada Health from a “sell (d+)” rating to a “sell (d)” rating in a report on Thursday, October 8th. BTIG Research reissued a “buy” rating and set a $35.00 price objective on shares of Omada Health in a research report on Friday, September 11th. Finally, Citigroup restated an “outperform” rating on shares of Omada Health in a report on Friday, August 14th. Eleven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.33.

Omada Health Trading Down 20.4%

Shares of OMDA stock traded down $3.86 during mid-day trading on Friday, reaching $15.09. The stock had a trading volume of 4,709,304 shares, compared to its average volume of 1,032,454. The firm has a market capitalization of $923.81 million, a PE ratio of 71.86 and a beta of 2.13. The stock’s 50-day moving average price is $20.14 and its two-hundred day moving average price is $17.74. Omada Health has a 52-week low of $10.28 and a 52-week high of $25.45.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, November 5th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.08. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The company had revenue of $91.31 million during the quarter. On average, equities research analysts forecast that Omada Health will post 0.09 earnings per share for the current year.

Insider Activity at Omada Health

In related news, President Wei-Li Shao sold 4,036 shares of Omada Health stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $21.85, for a total transaction of $88,186.60. Following the transaction, the president owned 295,313 shares in the company, valued at approximately $6,452,589.05. The trade was a 1.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sean P. Duffy sold 12,944 shares of the stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $19.22, for a total transaction of $248,783.68. Following the sale, the chief executive officer directly owned 382,594 shares of the company’s stock, valued at approximately $7,353,456.68. This trade represents a 3.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 119,014 shares of company stock worth $2,711,405. Company insiders own 6.38% of the company’s stock.

Hedge Funds Weigh In On Omada Health

A number of institutional investors and hedge funds have recently modified their holdings of OMDA. Sterling Capital Management LLC lifted its holdings in Omada Health by 1,161.6% during the 3rd quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock valued at $33,000 after buying an additional 1,452 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in Omada Health during the second quarter worth $53,000. State of Alaska Department of Revenue bought a new stake in Omada Health during the 3rd quarter valued at $59,000. Versant Capital Management Inc boosted its position in Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after acquiring an additional 2,283 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. purchased a new position in shares of Omada Health in the 3rd quarter valued at $70,000.

Trending Headlines about Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Omada reported Q3 revenue of $91 million, up 34% year over year, and total members grew 36% to a record 1.1 million. Net income was $7 million versus a year-ago loss, while adjusted EBITDA increased to $12 million. The company also raised its full-year 2026 financial outlook. Omada Health Reports Third Quarter 2026 Results
• Positive Sentiment: Quarterly revenue exceeded FactSet’s estimate, and reported earnings also topped consensus estimates, providing evidence of stronger-than-expected operating performance. Earnings Flash: Q3 Revenue
• Neutral Sentiment: Unusual options activity was reported after Omada’s earnings, signaling heightened trading interest but not indicating a clear direction for the stock. Unusual Options Volume Report
• Negative Sentiment: Several analysts took a more cautious stance: Wells Fargo cut its price target to $19 and maintained an “equal weight” rating, while Zacks Research downgraded OMDA from “strong buy” to “hold.” Wells Fargo analyst actions Zacks Research analyst action
• Negative Sentiment: Barclays also lowered its target from $24 to $22, although it retained an “overweight” rating. Barclays analyst action

Omada Health Company Profile

Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.